Viewing Study NCT04273061

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:48 AM
Ignite Modification Date: 2026-02-01 @ 1:48 PM
Study NCT ID: NCT04273061
Status: RECRUITING
Last Update Posted: 2025-09-22
First Post: 2020-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
Sponsor: British Columbia Cancer Agency
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Lung Cancer View
None Gastrointestinal Cancer View
None Genitourinary Cancer View
None Gynecologic Cancer View
None Sarcoma View
None Unknown Primary Tumors View
None Head and Neck Cancer View
None Skin Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Genomic analysis View
None Atezolizumab View
None Whole genome and transcriptome analysis View
None Immune Burden Variant score View
None Immune checkpoint inhibition View
None Personalized OncoGenomics View
None Phase 2 View
None Precision targeting View